These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India. Huded CB; Bharath S; Chandra SR; Sivakumar PT; Varghese M; Subramanian S Asian J Psychiatr; 2015 Feb; 13():44-7. PubMed ID: 25468261 [TBL] [Abstract][Full Text] [Related]
11. Batch prepared protein standards for cerebrospinal fluid (CSF) biomarkers for neurodegeneration. Petzold A; Verwey NA; van Uffelen K; Blankenstein MA; Teunissen C J Neurosci Methods; 2010 Nov; 193(2):296-9. PubMed ID: 20832428 [TBL] [Abstract][Full Text] [Related]
13. Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis. Luo X; Shi H; Hou L; Zhong X; Chen X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chen J; Fang Y; He H; Ning Y Eur J Neurol; 2015 May; 22(5):853-8. PubMed ID: 25707998 [TBL] [Abstract][Full Text] [Related]
14. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come? Zetterberg H; Blennow K J Alzheimers Dis; 2013; 33 Suppl 1():S361-9. PubMed ID: 22710917 [TBL] [Abstract][Full Text] [Related]
16. The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie. Sancesario GM; Toniolo S; Chiasserini D; Di Santo SG; Zegeer J; Bernardi G; ; Musicco M; ; Caltagirone C; Parnetti L; Bernardini S J Alzheimers Dis; 2017; 55(4):1659-1666. PubMed ID: 27911328 [TBL] [Abstract][Full Text] [Related]